Nosocomial pneumonia: Third-group chinolone versus clindamycin/ceftriaxone in modulation of the acute phase reaction and outcome and cost efficacy

International Surgery

Volumn 91, Issue 5, 2006, Pages 272-275

  Reith, H Bernd ^a,b   Rauchschwalbe, Sonja K ^b   Mittelkötter, Ulrich ^b,c  

^a KLINIKUM KONSTANZ   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Acute phase reaction; Antibiotic treatment; Nosocomial pneumonia; Outcome

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE; CLINDAMYCIN; QUINOLONE DERIVATIVE;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; CROSS INFECTION; DRUG COMBINATION; ECONOMICS; FEMALE; HISTORY; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE-PHASE REACTION; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CLINDAMYCIN; COSTS AND COST ANALYSIS; CROSS INFECTION; DRUG THERAPY, COMBINATION; FEMALE; HISTORY, ANCIENT; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; QUINOLONES;

EID: 33750093518     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Greenaway CA, Embil J, Or PH, McLeod J, Dyck B, Nicolle LE. Nosocomial pneumonia on general medical and surgical wards in a tertiary care hospital. Infect Control Hosp Epidemiol 1997;18:749-756
2. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, for the Canadian Critical Care Trial Group. The attributable morbidity and mortality of ventilator associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249-1256
3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in ICU setting. Chest 2000;118:146-155
4. Schlueter B, Koenig B, Bergmann U, Muller FE, Koenig W. Interleukin 6-a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 1991;31:1663-1670
5. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112(suppl 6):321s-329s
6. Reith HB, Mittelkötter U, Maseizik T, Hager S, Beutner U, Ulrichs K et al. Peritonitis-monitoring mit procalcitonin und diagnostik von immunfunktionsstörungen durch HLA-DR expression auf monozyten. Chir Gastroenterol 1999;15(suppl 1):8-14
7. Berger D, Ott S, Schmidt UM, Bölke E, Seidelmann M, Beger HG. Determination of endotoxin-neutralizing capacity of plasma in post-surgical patients. J Surg Res 1996;28:130-139
8. Rote Liste. 2004 Arzneimittelverzeichnis für Deutschland Herausgeber. Frankfurt, Germany: Rote Liste Service GmbH, 2004
9. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-539
10. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000;117:1434-1442
11. Lode H, Erbes R, Geerdes-Fenge H, Raffenberg M, Mauch H. Nosokomiale pneumonie-epidemiologie, pathogenese und diagnostik. Der Internist 2000;11:1170-1179
12. Edbrooke DL, Hibbert CL, Kingsley JM, Smith S, Bright NM, Quinn JM. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 1999;27:1760-1767
13. Tyburski JG, Dente C, Wilson RF, Steffes C, Devlin J, Carlin AM et al. Differences in arterial and mixed venous IL-6 levels: the lungs as a source of cytokine storm in sepsis. Surgery 2001;130:748-751